ESSA Historical Income Statement
EPIX Stock | USD 8.49 0.07 0.82% |
Historical analysis of ESSA Pharma income statement accounts such as Selling General Administrative of 7.6 M or Total Revenue of 0.0 can show how well ESSA Pharma performed in making a profits. Evaluating ESSA Pharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of ESSA Pharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining ESSA Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ESSA Pharma is a good buy for the upcoming year.
ESSA |
About ESSA Income Statement Analysis
ESSA Pharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to ESSA Pharma shareholders. The income statement also shows ESSA investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
ESSA Pharma Income Statement Chart
ESSA Pharma Income Statement is one of the three primary financial statements used for reporting ESSA's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ESSA Pharma revenue and expense. ESSA Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, ESSA Pharma's Research Development is fairly stable compared to the past year. Cost Of Revenue is likely to rise to about 143.1 K in 2024, whereas Interest Expense is likely to drop 5,935 in 2024. Add Fundamental
Most accounts from ESSA Pharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into ESSA Pharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.At this time, ESSA Pharma's Research Development is fairly stable compared to the past year. Cost Of Revenue is likely to rise to about 143.1 K in 2024, whereas Interest Expense is likely to drop 5,935 in 2024.
ESSA Pharma income statement Correlations
Click cells to compare fundamentals
ESSA Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ESSA Pharma income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 618K | 22.2K | 14K | 6.9K | 6.2K | 5.9K | |
Selling General Administrative | 11.4M | 12.8M | 12.5M | 11.4M | 13.1M | 7.6M | |
Other Operating Expenses | 23.5M | 37.1M | 37.0M | 32.1M | 37.0M | 19.3M | |
Operating Income | (23.1M) | (36.9M) | (35.3M) | (26.6M) | (23.9M) | (25.1M) | |
Net Income From Continuing Ops | (23.4M) | (36.8M) | (35.1M) | (26.6M) | (23.9M) | (25.1M) | |
Ebit | (23.1M) | (36.9M) | (35.3M) | (26.6M) | (23.9M) | (25.1M) | |
Research Development | 12.1M | 24.3M | 24.4M | 21.3M | 24.5M | 25.7M | |
Cost Of Revenue | 110.3K | 109.5K | 121.8K | 118.5K | 136.3K | 143.1K | |
Total Operating Expenses | 23.5M | 37.1M | 37.0M | 32.1M | 37.0M | 19.3M | |
Income Before Tax | (23.7M) | (36.8M) | (35.2M) | (26.6M) | (23.9M) | (25.1M) | |
Total Other Income Expense Net | (618.7K) | 68.8K | 127.8K | 6.5K | 5.9K | 5.6K | |
Net Income Applicable To Common Shares | (12.8M) | (23.4M) | (36.8M) | (35.1M) | (31.6M) | (30.0M) | |
Net Income | (23.4M) | (36.8M) | (35.1M) | (26.6M) | (23.9M) | (25.1M) | |
Income Tax Expense | (289K) | (34.3K) | (112K) | 1.6K | 1.4K | 1.4K | |
Depreciation And Amortization | 110.3K | 109.5K | 121.8K | 118.5K | 136.3K | 75.6K | |
Ebitda | (23.0M) | (36.8M) | (35.2M) | (26.5M) | (23.8M) | (25.0M) | |
Interest Income | 559.7K | 235.0K | 1.7M | 5.6M | 6.4M | 6.7M | |
Tax Provision | (288.6K) | (34.3K) | (111.8K) | 1.6K | 1.4K | 1.4K | |
Net Interest Income | (58.4K) | 212.8K | 1.7M | 5.5M | 6.4M | 6.7M | |
Reconciled Depreciation | 110.3K | 109.5K | 121.8K | 118.5K | 136.3K | 87.8K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ESSA Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ESSA Pharma's short interest history, or implied volatility extrapolated from ESSA Pharma options trading.
Pair Trading with ESSA Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ESSA Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with ESSA Stock
0.7 | CLVRW | Clever Leaves Holdings | PairCorr |
Moving against ESSA Stock
0.61 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.59 | MEIP | MEI Pharma Financial Report 9th of May 2024 | PairCorr |
0.58 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
0.56 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.52 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to ESSA Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ESSA Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ESSA Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ESSA Pharma to buy it.
The correlation of ESSA Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ESSA Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ESSA Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ESSA Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for ESSA Stock analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Return On Assets (0.13) | Return On Equity (0.17) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.